Tag Archives: Treatment

FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of Asthma

Print this page London UK 9 September 2020 — GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) announced the US Food and Drug Administration (FDA) has approved a new indication for Trelegy Ellipta (fluticasone furoate / umeclidinium / vilanterol ‘FF/UMEC/VI’) for the treatment of asthma in patients aged 18 years and older adding to… Read More »

Trump to announce plasma treatment authorized for COVID-19

WASHINGTON — After expressing frustration at the slow pace of approval for coronavirus treatments, President Donald Trump was set to announce on Sunday the emergency authorization of convalescent plasma for COVID-19 patients. The announcement will come after days of White House officials suggesting there were politically motivated delays by the Food and Drug Administration in… Read More »